EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.27X leverage
Performance
- Low
- ₹1,485
- High
- ₹1,530
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,586
- Open Price₹1,530
- Previous Close₹1,510
- Volume105,451
- 50 DMA₹1,469.64
- 100 DMA₹1,429.32
- 200 DMA₹1,387.86
Investment Returns
- Over 1 Month -2.71%
- Over 3 Month + 5.06%
- Over 6 Month + 8.16%
- Over 1 Year + 27.77%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 32.7
- PEG Ratio
- 0.8
- Market Cap Cr
- 28,413
- P/B Ratio
- 6
- Average True Range
- 56.98
- EPS
- 47.73
- Dividend Yield
- 0.2
- MACD Signal
- 12.61
- RSI
- 50.76
- MFI
- 49.67
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,498.80
-11.5
(-0.76%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹1,500.31
- 50 Day
- ₹1,469.64
- 100 Day
- ₹1,429.32
- 200 Day
- ₹1,387.86
Resistance and Support
1504.73
- R3 1,568.67
- R2 1,549.33
- R1 1,524.07
- S1 1,479.47
- S2 1,460.13
- S3 1,434.87
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,498 As on 12 February, 2026 | 05:54
The Market Cap of Emcure Pharmaceuticals is ₹28413.1 Cr As on 12 February, 2026 | 05:54
The P/E ratio of Emcure Pharmaceuticals is 32.7 As on 12 February, 2026 | 05:54
The PB ratio of Emcure Pharmaceuticals is 6 As on 12 February, 2026 | 05:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.